Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction ca... von Kang, Yoon-Koo, Chen, Li-Tzong, Ryu, Min-Hee, Oh, Do-Youn, Oh, Sang Cheul, Chung, Hyun Cheol, Lee, Keun-Wook, Omori, Takeshi, Shitara, Kohei, Sakuramoto, Shinichi, Chung, Ik-Joo, Yamaguchi, Kensei, Kato, Ken, Sym, Sun Jin, Kadowaki, Shigenori, Tsuji, Kunihiro, Chen, Jen-Shi, Bai, Li-Yuan, Oh, Sung-Yong, Choda, Yasuhiro, Yasui, Hisateru, Takeuchi, Kentaro, Hirashima, Yoshinori, Hagihara, Shunsuke, Boku, Narikazu

Volltext

Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACT... von Kang, Yoon-Koo, Boku, Narikazu, Satoh, Taroh, Ryu, Min-Hee, Chao, Yee, Kato, Ken, Chung, Hyun Cheol, Chen, Jen-Shi, Muro, Kei, Kang, Won Ki, Yeh, Kun-Huei, Yoshikawa, Takaki, Oh, Sang Cheul, Bai, Li-Yuan, Tamura, Takao, Lee, Keun-Wook, Hamamoto, Yasuo, Kim, Jong Gwang, Chin, Keisho, Oh, Do-Youn, Minashi, Keiko, Cho, Jae Yong, Tsuda, Masahiro, Chen, Li-Tzong

Volltext

A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data von Chen, Li-Tzong, Satoh, Taroh, Ryu, Min-Hee, Chao, Yee, Kato, Ken, Chung, Hyun Cheol, Chen, Jen-Shi, Muro, Kei, Kang, Won Ki, Yeh, Kun-Huei, Yoshikawa, Takaki, Oh, Sang Cheul, Bai, Li-Yuan, Tamura, Takao, Lee, Keun-Wook, Hamamoto, Yasuo, Kim, Jong Gwang, Chin, Keisho, Oh, Do-Youn, Minashi, Keiko, Cho, Jae Yong, Tsuda, Masahiro, Sameshima, Hiroki, Kang, Yoon-Koo, Boku, Narikazu

Volltext

Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Stu... von UENO, Hideki, IOKA, Tatsuya, SHIMAMURA, Tomotaka, SHO, Masayuki, KITANO, Masayuki, CHENG, Ann-Lii, MIZUMOTO, Kazuhiro, CHEN, Jen-Shi, FURUSE, Junji, FUNAKOSHI, Akihiro, HATORI, Takashi, YAMAGUCHI, Taketo, IKEDA, Masafumi, EGAWA, Shinichi, SATO, Atsushi, OHASHI, Yasuo, OKUSAKA, Takuji, TANAKA, Masao, OHKAWA, Shinichi, YANAGIMOTO, Hiroaki, BOKU, Narikazu, FUKUTOMI, Akira, SUGIMORI, Kazuya, BABA, Hideo, YAMAO, Kenji

Volltext

Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors von Raymond, Eric, Dahan, Laetitia, Raoul, Jean-Luc, Bang, Yung-Jue, Borbath, Ivan, Lombard-Bohas, Catherine, Valle, Juan, Metrakos, Peter, Smith, Denis, Vinik, Aaron, Chen, Jen-Shi, Hörsch, Dieter, Hammel, Pascal, Wiedenmann, Bertram, Van Cutsem, Eric, Patyna, Shem, Lu, Dongrui Ray, Blanckmeister, Carolyn, Chao, Richard, Ruszniewski, Philippe

Volltext

Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial von Noh, Sung Hoon, Prof, Park, Sook Ryun, MD, Yang, Han-Kwang, Prof, Chung, Hyun Cheol, Prof, Chung, Ik-Joo, Prof, Kim, Sang-Woon, Prof, Kim, Hyung-Ho, MD, Choi, Jin-Hyuk, Prof, Kim, Hoon-Kyo, Prof, Yu, Wansik, Prof, Lee, Jong Inn, MD, Shin, Dong Bok, Prof, Ji, Jiafu, Prof, Chen, Jen-Shi, MD, Lim, Yunni, MS, Ha, Stella, MS, Bang, Yung-Jue, Prof

Volltext

Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab von Boku, Narikazu, Satoh, Taroh, Ryu, Min-Hee, Chao, Yee, Kato, Ken, Chung, Hyun Cheol, Chen, Jen-Shi, Muro, Kei, Kang, Won Ki, Yeh, Kun-Huei, Yoshikawa, Takaki, Oh, Sang Cheul, Bai, Li-Yuan, Tamura, Takao, Lee, Keun-Wook, Hamamoto, Yasuo, Kim, Jong Gwang, Chin, Keisho, Oh, Do-Youn, Minashi, Keiko, Cho, Jae Yong, Tsuda, Masahiro, Nishiyama, Taihei, Chen, Li-Tzong, Kang, Yoon-Koo

Volltext

Liposomal irinotecan in metastatic pancreatic adenocarcinoma in Asian patients: Subgroup analysis of the NAPOLI‐1 study von Bang, Yung‐Jue, Li, Chung‐Pin, Lee, Kyung‐Hun, Chiu, Chang‐Fang, Park, Joon Oh, Shan, Yan‐Shen, Kim, Jun Suk, Chen, Jen‐Shi, Shim, Hyun‐Jeong, Rau, Kun‐Ming, Choi, Hye Jin, Oh, Do‐Youn, Belanger, Bruce, Chen, Li‐Tzong

Volltext

Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study von Pant, Shubham, Schuler, Martin, Iyer, Gopa, Witt, Olaf, Doi, Toshihiko, Qin, Shukui, Tabernero, Josep, Lugowska, Iwona, Carranza, Omar, Arnold, Dirk, Gutierrez, Martin, Winter, Helen, Stuyckens, Kim, Crow, Lauren, Najmi, Saltanat, Thomas, Shibu, Santiago-Walker, Ademi, Triantos, Spyros, Sweiti, Hussein, Loriot, Yohann, Carranza, Omar, Coward, Jim, Joshua, Anthony, Karapetis, Christos, Hart, Christopher, Zhang, Alison, Prenen, Hans, Goeminne, Jean-Charles, Machiels, Jean-Pascal, Rottey, Sylvie, Corassa, Marcelo, Molin, Graziela Zibetti Dal, Tiscoski, Katsuki, Mak, Milena, Fu, Wei, Yao, Herui, Jiang, Haiping, Qin, Shukui, Chen, Baoshi, Yang, Yu, Loriot, Yohann, Le Tourneau, Christophe, Penel, Nicolas, Durando, Xavier, Emambux, Sheik, Folprecht, Gunnar, Arnold, Dirk, Schuler, Martin, Ahrens, Marit, Golf, Alexander, Haag, Georg Martin, Desuki, Alexander, Cazzaniga, Marina, Ciardiello, Fortunato, Koyama, Takafumi, Aogi, Kenjiro, Kuboki, Yasutoshi, Lee, Jungyun, Kim, Sung-Bae, Chang, Jong Hee, Kim, Yong-Man, Nam, Do-Hyun, Park, Jae-Sung, Lugowska, Iwona, Paz-Ares, Luis, Moreno, Victor, Calvo, Mariona, Falcon, Alejandro, Gonzalez, Antonio, Tabernero, Josep, Martinez Bueno, Alejandro, García-Corbacho, Javier, Chen, Jen-Shi, Hou, Ming-Feng, Chao, Yee, Rau, Kun-Ming, Chiu, Tai-Jan, Feng, Yin-Hsun, Hsu, Chih-Hung, Lai, Kuan-Ming, Yeh, Su-peng, Minchom, Anna, Welsh, Liam, Plummer, Ruth, Gutierrez, Martin, Arrowsmith, Edward, Pant, Shubham, Spigel, David Robert, Zandberg, Dan Paul, Doroshow, Deborah, Moezi, Mehdi, Paulson, Scott, Reardon, David, Ward, Patrick, Chaves, Jorge, Hussein, Atif, Manda, Sudhir, Richey, Stephen L, Tamura, David, Wilks, Sharon

Volltext

Survival outcomes of management in metastatic gastric adenocarcinoma patients von Hu, Huang-Ming, Tsai, Hui-Jen, Ku, Hsiu-Ying, Lo, Su-Shun, Shan, Yan-Shen, Chang, Hung-Chi, Chao, Yee, Chen, Jen-Shi, Chen, Shu-Chen, Chiang, Chun-Ju, Li, Anna Fen-Yau, Wang, Hsiu-Po, Wang, Tsang-En, Bai, Li-Yuan, Wu, Ming-Shiang, Chen, Li-Tzong, Liu, Tsang-Wu, Yang, Yi-Hsin

Volltext

Addition of ramucirumab or merestinib to standard first-line chemotherapy for locally advanced or metastatic biliary tract cancer: a randomised, double-blind, multicentre, phase 2... von Valle, Juan W, Vogel, Arndt, Denlinger, Crystal S, He, Aiwu Ruth, Bai, Li-Yuan, Orlova, Rashida, Van Cutsem, Eric, Adeva, Jorge, Chen, Li-Tzong, Obermannova, Radka, Ettrich, Thomas J, Chen, Jen-Shi, Wasan, Harpreet, Girvan, Allicia C, Zhang, Wei, Liu, Jiangang, Tang, Chunlao, Ebert, Philip J, Aggarwal, Amit, McNeely, Samuel C, Moser, Brian A, Oliveira, Joana M, Carlesi, Roberto, Walgren, Richard A, Oh, Do-Youn

Volltext

Associations of prognostic‐awareness‐transition patterns with emotional distress and quality of life during terminally ill cancer patients' last 6 months of life von Chen, Chen Hsiu, Wen, Fur‐Hsing, Chang, Wen‐Cheng, Hsieh, Chia‐Hsun, Chou, Wen‐Chi, Chen, Jen‐Shi, Tang, Siew Tzuh

Volltext

Prolonged grief disorder and depression are distinguishable syndromes: A latent transition analysis for bereaved family caregivers of cancer patients von Wen, Fur‐Hsing, Prigerson, Holly G., Chou, Wen‐Chi, Chen, Jen‐Shi, Chang, Wen‐Cheng, Hsu, Mei Huang, Tang, Siew Tzuh

Volltext

Associations of prognostic awareness/acceptance with psychological distress, existential suffering, and quality of life in terminally ill cancer patients' last year of life von Tang, Siew Tzuh, Chang, Wen-Cheng, Chen, Jen-Shi, Chou, Wen-Chi, Hsieh, Chia-Hsun, Chen, Chen H.

Volltext

Cardiovascular toxicity of immune checkpoint inhibitors in cancer patients: A review when cardiology meets immuno-oncology von Chen, Dong-Yi, Huang, Wen-Kuan, Chien-Chia Wu, Victor, Chang, Wen-Cheng, Chen, Jen-Shi, Chuang, Cheng-Keng, Chu, Pao-Hsien

Volltext

Associations of death‐preparedness states with bereavement outcomes for family caregivers of terminally ill cancer patients von Wen, Fur‐Hsing, Chou, Wen‐Chi, Hou, Ming‐Mo, Su, Po‐Jung, Shen, Wen‐Chi, Chen, Jen‐Shi, Chang, Wen‐Cheng, Hsu, Mei Huang, Tang, Siew Tzuh

Volltext

Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivol... von Satoh, Taroh, Kang, Yoon-Koo, Chao, Yee, Ryu, Min-Hee, Kato, Ken, Cheol Chung, Hyun, Chen, Jen-Shi, Muro, Kei, Ki Kang, Won, Yeh, Kun-Huei, Yoshikawa, Takaki, Oh, Sang Cheul, Bai, Li-Yuan, Tamura, Takao, Lee, Keun-Wook, Hamamoto, Yasuo, Kim, Jong Gwang, Chin, Keisho, Oh, Do-Youn, Minashi, Keiko, Cho, Jae Yong, Tsuda, Masahiro, Tanimoto, Mitsunobu, Chen, Li-Tzong, Boku, Narikazu

Volltext

Prognostic and predictive factors for Taiwanese patients with advanced biliary tract cancer undergoing frontline chemotherapy with gemcitabine and cisplatin: a real-world experienc... von Wu, Chiao-En, Chou, Wen-Chi, Hsieh, Chia-Hsun, Chang, John Wen-Cheng, Lin, Cheng-Yu, Yeh, Chun-Nan, Chen, Jen-Shi

Volltext

Accurate prognostic awareness and preference states influence the concordance between terminally ill cancer patients’ states of preferred and received life-sustaining treatments in... von Wen, Fur-Hsing, Chen, Jen-Shi, Chang, Wen-Cheng, Chou, Wen-Chi, Hsieh, Chia-Hsun, Tang, Siew Tzuh

Volltext

Accurate Prognostic Awareness Facilitates, Whereas Better Quality of Life and More Anxiety Symptoms Hinder End-of-Life Care Discussions: A Longitudinal Survey Study in Terminally I... von Tang, Siew Tzuh, Chen, Chen Hsiu, Wen, Fur-Hsing, Chen, Jen-Shi, Chang, Wen-Cheng, Hsieh, Chia-Hsun, Chou, Wen-Chi, Hou, Ming-Mo

Volltext